Search Result - Primary Antibodies

  • anti-CD106 / VCAM1 antibody [M/K-2] (FITC)
  • Cat. No: ARG20802  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, WB
  • Specificity: Mouse CD106. The clone MK-2 has been used in transplant studies to suppress cardiac rejection and induce long-term cardiac graft survival. The M/K-2 monoclonal antibody immunoprecipitates a peptide that gives a single band on SDS-PAGE gels with an apparent MW of ~100 kDa under reducing conditions and 92 kDa under non-reducing conditions.
  • Conjugation: FITC
  • anti-CD106 / VCAM1 antibody [M/K-2] (Biotin)
  • Cat. No: ARG20803  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, WB
  • Specificity: Mouse CD106. The clone MK-2 has been used in transplant studies to suppress cardiac rejection and induce long-term cardiac graft survival. The M/K-2 monoclonal antibody immunoprecipitates a peptide that gives a single band on SDS-PAGE gels with an apparent MW of ~100 kDa under reducing conditions and 92 kDa under non-reducing conditions.
  • Conjugation: Biotin
  • anti-CD106 / VCAM1 antibody [M/K-2] (PE)
  • Cat. No: ARG20804  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, WB
  • Specificity: Mouse CD106. The clone MK-2 has been used in transplant studies to suppress cardiac rejection and induce long-term cardiac graft survival. The M/K-2 monoclonal antibody immunoprecipitates a peptide that gives a single band on SDS-PAGE gels with an apparent MW of ~100 kDa under reducing conditions and 92 kDa under non-reducing conditions.
  • Conjugation: PE
  • anti-CD106 / VCAM1 antibody [M/K-2] (low endotoxin)
  • Cat. No: ARG20805  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, IHC-Fr, IP, WB
  • Specificity: Mouse CD106. The clone MK-2 has been used in transplant studies to suppress cardiac rejection and induce long-term cardiac graft survival. The M/K-2 monoclonal antibody immunoprecipitates a peptide that gives a single band on SDS-PAGE gels with an apparent MW of ~100 kDa under reducing conditions and 92 kDa under non-reducing conditions.
  • Conjugation: Un-conjugated
  • anti-CD102 / ICAM2 antibody [3C4]
  • Cat. No: ARG21102  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, ICC/IF, IHC-Fr, IP
  • Specificity: Mouse CD102. The clone 3C4 reacts with the cell surface glycoprotein mouse CD102 (ICAM-2), a ligand for the leucocyte integrin CD11a/CD18 (LFA-1). CD102 is constitutively expressed on T cells, B cells, and at high levels on vascular endothelial cells. It is also expressed on a variety of leukocyte cell lines. The 3C4 antibody blocks the interaction between ICAM-2 and LFA-1.
  • Conjugation: Un-conjugated
  • anti-CD102 / ICAM2 antibody [3C4] (FITC)
  • Cat. No: ARG21103  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, ICC/IF, IHC-Fr
  • Specificity: Mouse CD102. The clone 3C4 reacts with the cell surface glycoprotein mouse CD102 (ICAM-2), a ligand for the leucocyte integrin CD11a/CD18 (LFA-1). CD102 is constitutively expressed on T cells, B cells, and at high levels on vascular endothelial cells. It is also expressed on a variety of leukocyte cell lines. The 3C4 antibody blocks the interaction between ICAM-2 and LFA-1.
  • Conjugation: FITC
  • anti-CD102 / ICAM2 antibody [3C4] (low endotoxin)
  • Cat. No: ARG21106  (Rat mAb)
  • Reactivity: Ms
  • Application: BL, FACS, ICC/IF, IHC-Fr, IP
  • Specificity: Mouse CD102. The clone 3C4 reacts with the cell surface glycoprotein mouse CD102 (ICAM-2), a ligand for the leucocyte integrin CD11a/CD18 (LFA-1). CD102 is constitutively expressed on T cells, B cells, and at high levels on vascular endothelial cells. It is also expressed on a variety of leukocyte cell lines. The 3C4 antibody blocks the interaction between ICAM-2 and LFA-1.
  • Conjugation: Un-conjugated
  • anti-CD107a / LAMP1 antibody
  • Cat. No: ARG55142  (Rabbit pAb)
  • Reactivity: Hu, Ms
  • Application: ICC/IF, IHC-P, WB
  • Conjugation: Un-conjugated